Profil
Martin Steiner is the founder of ImVisioN Therapeutics AG, which was founded in 2008.
He held the position of Director, Chief Executive & Financial Officer from 2011 to 2014.
Dr. Steiner is currently the President, Secretary, Treasurer & Director at ImVision Therapeutics, Inc. and Co-Managing Director at SYNIMMUNE GmbH since 2016.
In the past, he was the Chief Executive Officer at Apovia AG from 1997 to 2004 and Director-Business Development at Smithkline Beecham Biologicals Immunotherapeutics in 1997.
Dr. Steiner was also the Chief Executive & Financial Officer at ImVisioN GmbH.
Dr. Steiner holds an MBA from the University of Michigan and a doctorate from the University of Vienna.
Aktiva positioner av Martin Steiner
| Företag | Position | Start |
|---|---|---|
ImVision Therapeutics, Inc.
ImVision Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops proprietary technology for the delivery of immunotherapeutics in the treatment of allergies | President | - |
SYNIMMUNE GmbH
SYNIMMUNE GmbH Miscellaneous Commercial ServicesCommercial Services Operates as a bio technology company that develops antibodies | Verkställande Direktör | 2016-03-01 |
Tidigare kända positioner av Martin Steiner
| Företag | Position | Slut |
|---|---|---|
ImVisioN Therapeutics AG
ImVisioN Therapeutics AG Miscellaneous Commercial ServicesCommercial Services Operates as a holding company with interest in providing immunotherapy | Verkställande Direktör | 2014-02-13 |
Apovia AG | President | 2004-01-01 |
Smithkline Beecham Biologicals Immunotherapeutics | Företagsledare/Principal | 1997-01-01 |
ImVisioN GmbH
ImVisioN GmbH Miscellaneous Commercial ServicesCommercial Services Provides research in intralymphatic immunotherapy | Verkställande Direktör | - |
Martin Steiners utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
ImVision Therapeutics, Inc.
ImVision Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops proprietary technology for the delivery of immunotherapeutics in the treatment of allergies | Health Technology |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Vienna
University of Vienna Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImVisioN GmbH
ImVisioN GmbH Miscellaneous Commercial ServicesCommercial Services Provides research in intralymphatic immunotherapy | Commercial Services |
Apovia AG | |
ImVisioN Therapeutics AG
ImVisioN Therapeutics AG Miscellaneous Commercial ServicesCommercial Services Operates as a holding company with interest in providing immunotherapy | Commercial Services |
Smithkline Beecham Biologicals Immunotherapeutics | |
SYNIMMUNE GmbH
SYNIMMUNE GmbH Miscellaneous Commercial ServicesCommercial Services Operates as a bio technology company that develops antibodies | Commercial Services |
















